Cargando…
Photosensitivity Reactions to Vandetanib: Redevelopment after Sequential Treatment with Docetaxel
Vandetanib (ZD6474, Zactima™) is a novel, orally available inhibitor of different intracellular signaling pathways involved in tumor growth, progression, and angiogenesis, including vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and rearranged during transfection ty...
Autores principales: | Son, Young-Min, Roh, Joo-Young, Cho, Eun-Kyung, Lee, Jong-Rok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Dermatological Association; The Korean Society for Investigative Dermatology
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276785/ https://www.ncbi.nlm.nih.gov/pubmed/22346266 http://dx.doi.org/10.5021/ad.2011.23.S3.S314 |
Ejemplares similares
-
Causality Assessment of Cutaneous Adverse Drug Reactions
por: Son, Young-Min, et al.
Publicado: (2011) -
Vandetanib
por: Vozniak, J. Michael, et al.
Publicado: (2012) -
Redevelopment of Frenchay Hospital
por: Zorab, John S M
Publicado: (1987) -
Putting the “RT” in redevelopment
por: Jackman, Alean A.
Publicado: (2017) -
The Determinants of Brownfields Redevelopment in England
por: Longo, Alberto, et al.
Publicado: (2016)